Goodman Advisory Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $498 | Hold |
6
| – | – | ﹤0.01% | 143 |
|
|
2025
Q1 | $487 | Buy |
+6
| New | +$487 | ﹤0.01% | 177 |
|
|
2024
Q4 | – | Sell |
-6
| Closed | -$593 | – | 189 |
|
|
2024
Q3 | $593 | Hold |
6
| – | – | ﹤0.01% | 191 |
|
|
2024
Q2 | $556 | Sell |
6
-7
| -54% | -$649 | ﹤0.01% | 172 |
|
|
2024
Q1 | $1.23K | Hold |
13
| – | – | ﹤0.01% | 160 |
|
|
2023
Q4 | $1.16K | Hold |
13
| – | – | ﹤0.01% | 143 |
|
|
2023
Q3 | $949 | Hold |
13
| – | – | ﹤0.01% | 147 |
|
|
2023
Q2 | $1.08K | Hold |
13
| – | – | ﹤0.01% | 145 |
|
|
2023
Q1 | $991 | Hold |
13
| – | – | ﹤0.01% | 148 |
|
|
2022
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 140 |
|
|
2022
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 154 |
|
|
2022
Q2 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 167 |
|